Year: 2019
Type: review
Abstract: Targeted exosomal delivery systems for precision nanomedicine attract wide interest across areas of molecular cell biology, pharmaceutical sciences, and nanoengineering. Exosomes are naturally derived 50-150 nm nanovesicles that play important roles in cell-to-cell and/or cell-to-tissue communications and cross-species communication. Exosomes are also a promising class of novel drug delivery vehicles owing to their ability to shield their payload from chemical and enzymatic degradations as well as to evade recognition by and subsequent removal by the immune system. Combined with a new class of affinity ligands known as aptamers or chemical antibodies, molecularly targeted exosomes are poised to become the next generation of smartly engineered nanovesicles for precision medicine. Here, recent advances in targeted exosomal delivery systems engineered by aptamer for future strategies to promote human health using this class of human-derived nanovesicles are summarized.
Source: Advanced Materials
Institutions: Deakin University, Brigham and Women's Hospital, Harvard University, Ton Duc Thang University, Zhengzhou University, First Affiliated Hospital of Zhengzhou University, UNSW Sydney, St George Hospital, Shaanxi Normal University, Chinese Academy of Sciences, Suzhou Institute of Nano-tech and Nano-bionics
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funder: Australian Research Council
OpenAlex ID: W2974434865
